Abstract
Osteoporosis-related hip fractures represent a substantial cause of mortality and morbidity in industrialized countries like Austria. Identification of groups at high risk for mortality after hip fracture is crucial for health policy decisions. To determine in-hospital, long-term, and excess mortality after osteoporosis-related hip fracture in Austrian patients, we conducted a retrospective cohort analysis of pseudonymized invoice data from Austrian social insurance authorities covering roughly 98 % of the entire population. The data set included 31,668 subjects aged 50 years and above sustaining a hip fracture between July 2008 and December 2010 with follow-up until June 2011, and an age-, gender-, and regionally matched control population without hip fractures (56,320 subjects). Kaplan–Meier and Cox hazard regression analyses served to determine unadjusted and adjusted mortality rates: Unadjusted all-cause 1-year mortality amounted to 20.2 % (95 % CI: 19.7–20.7 %). Males had significantly higher long-term, in-hospital, and excess mortality rates than females, but younger males exhibited lower excess mortality than their female counterparts. Advanced age correlated with increased long-term and in-hospital mortality, but lower excess mortality. Excess mortality, particularly in males, was highest in the first 6 months after hip fracture, but remained statistically significantly elevated throughout the observation period of 3 years. Longer hospital stay per fracture was correlated with mortality reduction in older patients and in patients with more subsequent fractures. In conclusion, more efforts are needed to identify causes and effectively prevent excess mortality especially in male osteoporosis patients.
Similar content being viewed by others
References
Dhanwal DK, Dennison EM, Harvey NC, Cooper C (2011) Epidemiology of hip fracture: worldwide geographic variation. Indian J Orthop 45:15–22
Haleem S, Lutchman L, Mayahi R, Grice JE, Parker MJ (2008) Mortality following hip fracture: trends and geographical variations over the last 40 years. Injury 39:1157–1163
Armstrong AL, Wallace WA (1994) The epidemiology of hip fractures and methods of prevention. Acta Orthop Belg 60(Suppl 1):85–101
McClung MR (2003) Pathogenesis of osteoporotic hip fractures. Clin Cornerstone 5(Suppl 2):22–29
Abrahamsen B, Vestergaard P (2010) Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997–2006. Osteoporos Int 21:373–380
Maravic M, Taupin P, Landais P, Roux C (2011) Change in hip fracture incidence over the last 6 years in France. Osteoporos Int 22:797–801
Støen RO, Nordsletten L, Meyer HE, Frihagen JF, Falch JA, Lofthus CM (2012) Hip fracture incidence is decreasing in the high incidence area of Oslo, Norway. Osteoporos Int 23:2527–2534
Dimai HP, Svedbom A, Fahrleitner-Pammer A, Pieber T, Resch H, Zwettler E et al (2011) Epidemiology of hip fractures in Austria: evidence for a change in the secular trend. Osteoporos Int 22:685–692
Giversen IM (2007) Time trends of mortality after first hip fractures. Osteoporos Int 18:721–732
Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C (2012) A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int 23:2239–2256
Miyamoto RG, Kaplan KM, Levine BR, Egol KA, Zuckerman JD (2008) Surgical management of hip fractures: an evidence-based review of the literature. I: femoral neck fractures. J Am Acad Orthop Surg 16:596–607
Vestergaard P, Rejnmark L, Mosekilde L (2007) Increased mortality in patients with a hip fracture-effect of pre-morbid conditions and post-fracture complications. Osteoporos Int 18:1583–1593
Haentjens P, Magaziner J, Colón-Emeric CS, Vanderschueren D, Milisen K, Velkeniers B et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380–390
Tosteson ANA, Gottlieb DJ, Radley DC, Fisher ES, Melton LJ III (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463–1472
Rapp K, Becker C, Lamb SE, Icks A, Klenk J (2008) Hip fractures in institutionalized elderly people: incidence rates and excess mortality. J Bone Miner Res 23:1825–1831
Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20:1633–1650
Frost SA, Nguyen ND, Black DA, Eisman JA, Nguyen TV (2011) Risk factors for in-hospital post-hip fracture mortality. Bone 49:553–558
Belmont PJ Jr, Garcia EJ, Romano DM, Bader JO, Nelson KJ, Schoenfeld AJ (2014) Risk factors for complications and in-hospital mortality following hip fractures: a study using the National Trauma Data Bank. Arch Orthop Trauma Surg 134:597–604
Norring-Agerskov D, Laulund AS, Bruun Lauritzen J, Rønnov Duus B, van der Mark S, Mosfeldt M et al (2013) Metaanalysis of risk factors for mortality in patients with hip fracture. Dan Med J 60:A4675
Farahmand BY, Michaëlsson K, Ahlbom A, Ljunghall S, Baron JA (2005) Survival after hip fracture. Osteoporos Int 16:1583–1590
Koeck CM, Schwappach DLB, Niemann FM, Strassmann TJ, Ebner H, Klaushofer K (2001) Incidence and costs of osteoporosis-associated hip fractures in Austria. Wien Klin Wochenschr 113:371–377
Dorner T, Weichselbaum E, Lawrence K, Stein KV, Rieder A (2009) Austrian osteoporosis report: epidemiology, lifestyle factors, public health strategies. Wien Med Wochenschr 159:221–229
World Health Organization (2004) ICD-10: International statistical classification of diseases and related health problems (10th rev., 2nded.). World Health Organization, Geneva.
Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B (2010) Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 39:203–209
Kang H-Y, Yang K-H, Kim YN, Moon S-H, Choi W-J, Kang DR et al (2010) Incidence and mortality of hip fracture among the elderly population in South Korea: a population-based study using the National Health Insurance claims data. BMC Public Health 10:230
Chau PH, Wong M, Lee A, Ling M, Woo J (2013) Trends in hip fracture incidence and mortality in Chinese population from Hong Kong 2001-09. Age Ageing 42:229–233
Bass E, French DD, Bradham DD, Rubenstein LZ (2007) Risk-adjusted mortality rates of elderly veterans with hip fractures. Ann Epidemiol 17:514–519
Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22:2439–2448
Laubjerg Daugaard C, Jørgensen HL, Riis T, Lauritzen JB, Duus BR, van der Mark S (2012) Is mortality after hip fracture associated with surgical delay or admission during weekends and public holidays? A retrospective study of 38,020 patients. Acta Orthop 83:609–613
Su H, Aharonoff GB, Hiebert R, Zuckerman JD, Koval KJ (2003) In-hospital mortality after femoral neck fracture: do internal fixation and hemiarthroplasty differ? Am J Orthop 32:151–155
Bottle A, Aylin P (2006) Mortality associated with delay in operation after hip fracture: observational study. BMJ 332:947–951
Yoon H-K, Park C, Jang S, Jang S, Lee Y-K, Ha Y-C (2011) Incidence and mortality following hip fracture in Korea. J Korean Med Sci 26:1087–1092
Wang C-B, Lin C-FJ, Liang W-M, Cheng C-F, Chang Y-J, Wu H-C et al (2013) Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone 56:147–153
Kondo A, Zierler BK, Isokawa Y, Hagino H, Ito Y, Richerson M (2010) Comparison of lengths of hospital stay after surgery and mortality in elderly hip fracture patients between Japan and the United States – the relationship between the lengths of hospital stay after surgery and mortality. Disabil Rehabil 32:826–835
Williams N, Hardy BM, Tarrant S, Enninghorst N, Attia J, Oldmeadow C et al (2013) Changes in hip fracture incidence, mortality and length of stay over the last decade in an Australian major trauma centre. Arch Osteoporos 8:150
Sterling RS (2011) Gender and race/ethnicity differences in hip fracture incidence, morbidity, mortality, and function. Clin Orthop Relat Res 469:1913–1918
Zwettler E, Eichbauer H, Lehner E, Vargas J, Bakewell S, Kara M et al (2009) Secondary hip fracture prevention through integrated clinical approaches involving specialists, general practitioners and nurses. Bone 44(Suppl 2):201
Kammerlander C, Gosch M, Blauth M, Lechleitner M, Luger TJ, Roth T (2011) The Tyrolean Geriatric Fracture Center: an orthogeriatric co-management model. Z Gerontol Geriatr 44:363–367
Mikosch P, Gosch M (2013) Osteoporose – Therapie und sektorenübergreifendes Management. Wien Med Wochenschr 163:455–461
Kammerlander C, Roth T, Friedman SM, Suhm N, Luger TJ, Kammerlander-Knauer U et al (2010) Ortho-geriatric service—a literature review comparing different models. Osteoporos Int 21(Suppl 4):S637–S646
Gosch M, Roth T, Kammerlander C, Joosten-Gstrein B, Benvenuti-Falger U, Blauth M et al (2011) Treatment of osteoporosis in postmenopausal hip fracture patients after geriatric rehabilitation: changes over the last decade. Z Gerontol Geriatr 44:381–386
Kammerlander C, Gosch M, Kammerlander-Knauer U, Luger TJ, Blauth M, Roth T (2011) Long-term functional outcome in geriatric hip fracture patients. Arch Orthop Trauma Surg 131:1435–1444
Alves SM, Economou T, Oliveira C, Ribeiro AI, Neves N, Goméz-Barrena E et al (2013) Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study. Bone 53:430–436
Fisher AA, O´Brien ED, Davis MW (2009) Trends in hip fracture epidemiology in Australia: possible impact of bisphosphonates and hormone replacement therapy. Bone 45:246–253
Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357:1799–1809
Beaupre LA, Morrish DW, Hanley DA, Maksymowych WP, Bell NR, Juby AG et al (2011) Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int 22:983–991
Bondo L, Eiken P, Abrahamsen B (2013) Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos Int 24:245–252
Acknowledgments
We thank Katrin Danninger (Oberösterreichische Gebietskrankenkasse), Alexandra Ferdin (Versicherungsanstalt öffentlich Bediensteter), Jana Fischer (Niederösterreichische Gebietskrankenkasse), Peter Haubenberger (Sozialversicherungsanstalt der Gewerblichen Wirtschaft), Michael Hueber (Versicherungsanstalt für Eisenbahnen und Bergbau), Renato Kasseroller (Salzburger Gebietskrankenkasse), Claudia Kastelic (Sozialversicherungsanstalt der Bauern), Tobias Lingenhöle (Vorarlberger Gebietskrankenkasse), Ursula Riess (Kärntner Gebietskrankenkasse), Marianne Schmid (Steiermärkische Gebietskrankenkasse), Cornelia Siess (Wiener Gebietskrankenkasse), and Norbert Thiemann (Tiroler Gebietskrankenkasse) from the Austrian social insurance authorities for provision of the data.
Human and Animal Rights and Informed Consent
The local Ethics Committee approved the study which was performed according to the Declaration of Helsinki.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors declare that they have no conflict of interest.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Brozek, W., Reichardt, B., Kimberger, O. et al. Mortality After Hip Fracture in Austria 2008–2011. Calcif Tissue Int 95, 257–266 (2014). https://doi.org/10.1007/s00223-014-9889-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-014-9889-9